Temple Therapeutics Holdings Ltd — Form D

Temple Therapeutics Holdings Ltd of GELEEN, P7, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-03. The offering totals $10.0M, of which $150K was reported sold. Industry: Biotechnology.

Offering

Filed: 2022-01-03
Form: D
Accession: 0001213900-22-000108
Industry: Biotechnology
Exemptions: 06b
Total offering: $10.0M
Amount sold: $150K
Remaining: $9.8M
Minimum investment: $100K
Investors: 3
Date of first sale: 2021-11-13
Security types: debt
Revenue range: No Revenues
SEC file number: 021-427586

Issuer

Name: Temple Therapeutics Holdings Ltd
CIK: 0001896459
Entity type: Corporation
Jurisdiction: CAYMAN ISLANDS
Incorporated: 2020
Address: URMONDERBAAN 22, GATE 2, GELEEN, P7, 6167 RD
Phone: 3062615189

Officers, directors & promoters (2)

Name	Role	Location
Sanj Singh	Director	Saskatoon, A9
Sanj Singh	Executive Officer	Saskatoon, A9

Other filings by this issuer (6)

Filed	Form	Offering	Sold
2023-12-26	D	$5.0M	$25K
2023-12-26	D	$3.5M	$200K
2023-12-26	D	$3.5M	$100K
2022-05-27	D	$350K	$350K
2022-05-27	D	$600K	$600K
2021-12-09	D	$1.0M	$300K

More